Laminin alpha 5 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-18714
Key Product Details
Species Reactivity
Validated:
Mouse
Cited:
Mouse
Applications
Validated:
ELISA, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot
Cited:
IF/IHC
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
This product is unpurified. The exact concentration of antibody is not quantifiable.
Product Specifications
Immunogen
Synthetic peptide derived from Cter domain of Lama5 protein
Specificity
Reacts specifically with mouse 404 kDa protein
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for Laminin alpha 5 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
1:50 - 1:200
Western Blot
1:200 - 1:1000
Application Notes
Use in IHC reported in scientific literature (PMID: 30139844).
Reviewed Applications
Read 1 review rated 1 using NBP1-18714 in the following applications:
Formulation, Preparation, and Storage
Purification
Unpurified
Reconstitution
Reconstitute in distilled water.
Formulation
Antiserum
Preservative
No Preservative
Concentration
This product is unpurified. The exact concentration of antibody is not quantifiable.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Laminin alpha 5
Alternate Names
KIAA0533, KIAA1907, laminin alpha-5 chain, laminin subunit alpha-5, laminin, alpha 5, Laminin-10 subunit alpha, Laminin-11 subunit alpha, Laminin-15 subunit alpha
Entrez Gene IDs
16776 (Mouse)
Gene Symbol
LAMA5
UniProt
Additional Laminin alpha 5 Products
Product Documents for Laminin alpha 5 Antibody
Product Specific Notices for Laminin alpha 5 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...